PDUFA Update: FDA Wants To Automatically Extend Complex Application Reviews

FDA wants industry to agree to a set of reasons that would automatically trigger a longer application review as part of the negotiations on reauthorizing the Prescription Drug User Fee Act.

More from Archive

More from Pink Sheet